<DOC>
	<DOCNO>NCT01306240</DOCNO>
	<brief_summary>Term near term newborn present acute respiratory distress syndrome ( RDS ) . Surfactant treatment show effective reduce mechanical ventilation oxygen treatment duration preterm newborn . Whether surfactant treatment beneficial term near term newborn unknown . The purpose study compare surfactant treatment vs. nasal continuous positive airway pressure newborn 35 41 week gestation RDS within first 24 hour life . The study 's primary endpoint `` survival oxygen treatment 72 hour life '' . The secondary endpoint : death , surfactant treatment , pneumothorax , secondary infection , pulmonary hypertension , inhale nitric oxide treatment , fluid loading treatment , vasopressive amine treatment , mechanical ventilation duration , nCPAP treatment duration , Oxygen treatment duration , Oxygen treatment 28 day life , hospitalization duration treatment strategy cost .</brief_summary>
	<brief_title>Surfactant Versus Nasal Continuous Positive Airway Pressure ( nCPAP ) Respiratory Distress Syndrome Newborn ≥ 35 Weeks Gestation</brief_title>
	<detailed_description>Newborn 35 41 week gestation RDS within first 24 hour life , treat nCPAP FiO2 ≥ 30 % eligible . Randomisation stratify centre 2 age group ( 35-36 week gestation 37-41 week ogf gestation ) . One arm receive surfactant treatment tracheal intubation . The second arm continue nCPAP . A rescue treatment use second arm FiO2 &gt; 60 % . In arm newborn wean mechanical ventilation oxygen treatment soon possible . The primary outcome study success procedure define `` survival without oxygen treatment '' 72 hour life .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<mesh_term>Poractant alfa</mesh_term>
	<criteria>Gestational age 35 41 week gestation &lt; 24 hour life Nasal Continuous Positive Airways Pressure ( nCPAP ) 1 hour FiO2 ≥ 30 % nCPAP target postductus arteriosus SpO2 &gt; 92 % Written consent parent FiO2 &gt; 60 % nCPAP , ou FiO2 &gt; 40 % 3 consecutives hour whatever respiratory support Life threaten congenital pathology Congenital cardiopathy ( except patent ductus arteriosus ) Shock define systemic hypotension ( mean blood pressure &lt; 10th percentile normal range birth weight postnatal age ) least 3 follow criterion decrease perfusion : 1 ) tachycardia ( heart rate &gt; 160 beats/min ) ; 2 ) abnormal peripheral pulse ; 3 ) modify extremity coloration ; 4 ) prolong capillary refill time &gt; 3 second ; 5 ) urine output &lt; 1 ml/kg/h Blood gas pH &lt; 7.19 / PCO2 &gt; 65 mmHg Apgar score ≤ 3 5 minute life</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Infant newborn</keyword>
	<keyword>Infant preterm</keyword>
	<keyword>Acute respiratory distress syndrome</keyword>
	<keyword>surfactant</keyword>
	<keyword>Hyaline Membrane disease</keyword>
	<keyword>Newborn acute respiratory distress syndrome ( ARDS )</keyword>
</DOC>